BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8908536)

  • 1. Adhesion molecules in primary biliary cirrhosis and primary sclerosing cholangitis.
    Broomé U; Hauzenberger D; Klominek J
    Hepatogastroenterology; 1996; 43(11):1109-12. PubMed ID: 8908536
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.
    Adams DH; Hubscher SG; Shaw J; Johnson GD; Babbs C; Rothlein R; Neuberger JM
    Hepatology; 1991 Sep; 14(3):426-31. PubMed ID: 1714872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis.
    Borchers AT; Shimoda S; Bowlus C; Keen CL; Gershwin ME
    Semin Immunopathol; 2009 Sep; 31(3):309-22. PubMed ID: 19533132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis.
    Broomé U; Hultcrantz R; Scheynius A
    Scand J Gastroenterol; 1993 Feb; 28(2):126-30. PubMed ID: 8095102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined liver damage from primary biliary cirrhosis, primary sclerosing cholangitis, liver allograft rejection and graft-versus-host disease].
    Kogan J; Ilan I
    Harefuah; 2000 Jan; 138(1):38-41. PubMed ID: 10868178
    [No Abstract]   [Full Text] [Related]  

  • 6. Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.
    Bloom S; Fleming K; Chapman R
    Gut; 1995 Apr; 36(4):604-9. PubMed ID: 7537707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis].
    Stiehl A
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():29-30. PubMed ID: 12467002
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases.
    Adams DH; Mainolfi E; Burra P; Neuberger JM; Ayres R; Elias E; Rothlein R
    Hepatology; 1992 Sep; 16(3):810-4. PubMed ID: 1354635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence and prevalence of autoimmune liver diseases].
    Berdal JE; Ebbesen J; Rydning A
    Tidsskr Nor Laegeforen; 1998 Nov; 118(29):4517-9. PubMed ID: 9889636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of adhesion molecules in allergic inflammation and their suitability as targets of antiallergic therapy.
    Schleimer RP; Bochner BS
    Clin Exp Allergy; 1998 Aug; 28 Suppl 3():15-23. PubMed ID: 9756182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential V beta3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis.
    Broomé U; Grunewald J; Scheynius A; Olerup O; Hultcrantz R
    J Hepatol; 1997 Mar; 26(3):527-34. PubMed ID: 9075659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis.
    Sasatomi K; Noguchi K; Sakisaka S; Sata M; Tanikawa K
    J Hepatol; 1998 Sep; 29(3):409-16. PubMed ID: 9764987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoimmune liver diseases. Part I].
    Ziółkowski J; Zagozdzon R; Paczek L
    Przegl Lek; 1999; 56(5):385-9. PubMed ID: 10554578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbes as trigger for primary biliary cirrhosis and primary sclerosing cholangitis.
    Ljungh A; Nilsson HO; Wadström T; Stenram U; Willén R
    Dig Liver Dis; 2005 Oct; 37(10):803-4. PubMed ID: 15998605
    [No Abstract]   [Full Text] [Related]  

  • 16. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
    Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
    Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesion molecules.
    van den Oord JJ
    Hepatogastroenterology; 1996; 43(11):1100-2. PubMed ID: 8908533
    [No Abstract]   [Full Text] [Related]  

  • 18. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis.
    Lim AG; Jazrawi RP; Ahmed HA; Levy JH; Zuin M; Douds AC; Maxwell JD; Northfield TC
    Hepatology; 1994 Oct; 20(4 Pt 1):882-8. PubMed ID: 7927229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study.
    Medina J; Sanz-Cameno P; García-Buey L; Martín-Vílchez S; López-Cabrera M; Moreno-Otero R
    J Hepatol; 2005 Jan; 42(1):124-31. PubMed ID: 15629517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biliary autoimmune disease of the liver: morphologic differential diagnosis].
    Lobeck H; Hopf U; Pohl C; Neuhaus P
    Verh Dtsch Ges Pathol; 1997; 81():706-9. PubMed ID: 9474893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.